Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Kingworld Medicines Group Ltd. has announced the completion of the topping out process for its Longde Health Industrial Park and has obtained relevant building ownership certificates. The strategically located project in Shenzhen aims to leverage the Greater Bay Area’s benefits to enhance the company’s competitive edge and shareholder value. The development is part of a major initiative to consolidate pharmaceutical resources in the region.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.
